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Introduction
The interneuronal relationship between rod and cone photore-
ceptors in humans and mice is such that rod death always leads 
to cone death, while conversely, loss of cones has only a mini-
mal effect on rods (1–4). This phenomenon plays a central role in 
retinitis pigmentosa (RP), since mutations in a few rod photore-
ceptor–specific genes affect a disproportionately large number of 
patients (5) (RetNet: https://sph.uth.edu/retnet/). Because cones 
are essential for daylight, color, and high-acuity vision, it is their 
loss that leads to blindness. The fact that cone death always fol-
lows rod death independently of the underlying mutation in a 
rod-specific gene suggests that the reason(s) for cone death might 
be similar across various forms of RP. Thus, targeting the com-
mon mechanism(s) of cone death may allow for the development 
of vision therapies with broad clinical significance.
Many theories have been proposed to explain the dependence 
of cones on rods. Such theories include the production of toxic 
byproducts from dying rods, the loss of rod trophic support as 
rods die (6–11), overactive microglia recruited to remove the dying 
rods, and increased oxidative stress (12–16). We recently proposed 
a different theory suggesting that cones suffer from a nutrient 
shortage induced by disruption of the retinal architecture once 
most rods have been lost (17). Because rods outnumber cones at 
a greater than 20:1 ratio and photoreceptors account for approxi-
mately 75% of all retinal cells, loss of rods severely alters the retinal 
architecture (18, 19). Thus, we hypothesized that once rod death 
progresses beyond a critical threshold, cone death initiates as a 
cell-autonomous event due to a reduction in nutrient flow from 
the adjacent cell layer, the retinal pigmented epithelium (RPE) 
(17). This hypothesis was based on the following findings: First, 
cone death always initiates only after approximately 90% of rods 
have died, irrespective of the rod death kinetics. Second, during 
the period of cone degeneration, cones display signs of prolonged 
starvation. Finally, during cone death, we observed gene expres-
sion changes in many metabolic genes and genes of the insulin/
mTOR pathway, a key pathway controlling cell metabolism (17). 
To test whether activation of the insulin/mTOR pathway alters 
cone survival, we treated the fast-progressing rd1 mouse model 
(20) of RP with daily systemic injections of insulin (17). While cone 
survival did improve, the therapeutic effect of insulin lasted only 
for a period of 4 weeks, possibly due to the negative-feedback loop 
within the insulin/mTOR pathway (Figure 1 and refs. 17, 21). Our 
findings, though encouraging, left many questions unanswered 
regarding the role of mTOR and its potential as a therapeutic tar-
get to promote cone survival in RP. As such, it remained unclear 
whether insulin acts directly on cones to improve cone survival, or 
whether it stimulates other cells such as RPE cells or retinal Müller 
glia cells to release neuroprotective factors, as its administration 
was systemic. It was also unclear whether the protective effect of 
insulin requires mTOR activity and whether, by circumventing 
the feedback mechanism within the insulin/mTOR pathway, cone 
survival can be prolonged to the point of being therapeutically rel-
evant to humans. Last, it remained to be tested whether the effect 
of insulin can be extended to other mouse models of RP, giving it a 
broader clinical significance.
To evaluate the long-term therapeutic potential of the insu-
lin/mTOR pathway on cone survival and to test whether insulin 
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are central to the insulin/mTOR pathway are protein kinase B 
(PKB), also known as AKT, and mTOR (21, 28–30). AKT has 3 
isoforms that are often cell-type specific and a multitude of tar-
gets. In contrast, mTOR is found in 2 large protein complexes 
referred to as mTORC1 and mTORC2, each with a small, distinct 
set of known targets and characterized by their unique accessory 
proteins RAPTOR and RICTOR, respectively (21). Both AKT and 
mTORC2 respond mainly to growth factor changes and control 
many prosurvival mechanisms, while mTORC1 is growth factor 
and nutrient sensitive and regulates mainly cellular growth pro-
cesses (21) (Figure 1). To identify which kinase(s) downstream of 
PTEN promote(s) cone survival, we first assessed the phospho-
rylation status of AKT and other bona fide targets of both mTOR 
complexes. Western blot analyses from whole retinal extracts at 
the onset of cone death (17) (P21) showed no appreciable phos-
phorylation changes, a result that could be explained by the low 
proportion of cones in the retina (3%) (18, 19, 31) and/or the high 
expression levels of these phosphorylated proteins in other retinal 
cell types (Supplemental Figure 2, B and C). However, immuno-
fluorescence on retinal flat mounts at P21 revealed an increase in 
the number of cones positive for 3-phosphosinositide–dependent 
protein kinase (PDK1) phosphorylation of AKT at Thr308 and a 
decrease in the number of cones positive for mTORC2-mediated 
phosphorylation of AKT at Ser473 (Figure 2C and ref. 21). Con-
sistent with this finding, the number of cones positive for phos-
phorylated serum/glucocorticoid-regulated kinase 1 (p-SGK1), 
another mTORC2 target, was also reduced, while the number of 
cones phosphorylated on ribosomal protein S6 (p-S6), an indirect 
mTORC1 target (21), was increased (Figure 2C). Since phospho-
rylation of AKT on both sites is required for most AKT-mediated 
prosurvival functions, but phosphorylation on Thr308 is suffi-
cient to activate mTORC1, the data suggest that cone survival 
upon loss of PTEN is mediated mainly by increased mTORC1 
activity (21, 29, 32). The reduction in mTORC2 activity upon 
loss of PTEN is likely due to the inhibitory effect of mTORC1 on 
mTORC2 (33, 34).
To test whether increased mTORC1 activity is responsible 
for the survival effect mediated by loss of PTEN, we generated 
rd1 mice with simultaneous deletion of Pten and Raptor in cones 
(rd1 M-opsin-Cre Ptenfl/fl Raptorfl/fl allele; ref. 35 and Figure 1) and 
quantified cone survival in these mice at 2 months of age, a time 
point at which the difference in cone survival was quite large 
following loss of PTEN. Interestingly, concurrent loss of PTEN 
and RAPTOR not only abolished the survival effect seen upon 
loss of PTEN, but also accelerated cone death (Figure 3, A and 
B). A similar acceleration of cone death was seen upon loss of 
RAPTOR alone (Figure 3, A and B), while loss of RAPTOR in 
cones of WT mice did not affect cone survival at 2 months of age 
(data not shown). In contrast, loss of RICTOR (Rictorfl/fl allele; 
ref. 36) in cones had no effect on cone survival in rd1 (Figure 3, A 
and B) or WT mice (data not shown) at 2 months of age. Loss of 
RAPTOR and RICTOR was verified by phosphorylation changes 
in their downstream targets (21) S6, AKT, and SGK1 (Figure 
3, C and D). The results show that mTORC1 activity is not only 
required for the improved cone survival seen upon loss of PTEN, 
but is also critical for cone survival under the stress conditions 
encountered during disease. Furthermore, the data suggest that 
acts directly on cones through this pathway, we have now consti-
tutively activated this pathway in cones. Through the use of vari-
ous conditional alleles of genes downstream of the insulin recep-
tor (Figure 1) that were deleted using the same cone-specific Cre 
recombinase line (ref. 22 and Supplemental Figure 1, A–E; sup-
plemental material available online with this article; doi:10.1172/
JCI79766DS1), we show that mTORC1 activity in cones is required 
to slow the progression of the disease and that constitutively 
active mTORC1 in cones is sufficient to significantly prolong cone 
survival and maintain cone function. This mechanism of protec-
tion functions in the fast-progressing rd1 mouse model of RP and 
in the slow-progressing rhodopsin-KO (Rho-KO) (23) model. Acti-
vated mTORC1 increases the expression of genes that improve 
glucose uptake, retention, and utilization, resulting in increased 
NADPH levels. Because low NADPH levels can trigger cell death 
by activation of the initiator caspase, caspase 2 (CASP2) (24, 25), 
we crossed caspase 2–deficient mice (Casp2–/–) (26) with the fast- 
progressing rd1 model of the disease, which slowed the progression 
of cone death. In summary, our results show that cell-autonomous 
activation of mTORC1 in cones is sufficient to promote long-term 
cone survival and that high glucose and NADPH levels are crucial 
for cone survival, indicating that the secondary loss of cones in RP 
is mainly due to a nutrient imbalance. Therapies aimed at increas-
ing mTORC1 activity in cones or increasing the expression of key 
metabolic target genes of mTORC1 are thus plausible strategies to 
prolong vision in humans suffering from RP.
Results
mTORC1 is required and sufficient to promote cone survival in RP. 
To evaluate whether insulin acts directly on cones through the 
insulin/mTOR pathway and to test whether continued stimulation 
of the pathway significantly prolongs cone survival, we constitu-
tively activated the pathway in cones of rd1 mice by conditional 
deletion of the tumor-suppressor gene phosphatase and tension 
homolog (Pten) using the Cre-lox system (21, 27) (rd1 M-opsin-Cre 
Ptenfl/fl mice, herein referred to as rd1 PtencKO mice. cKO denotes 
cone KO; in all instances, Cre+ denotes cKO of the gene indicated; 
the same cone-specific Cre driver line [M-opsin-Cre mice] [ref. 22] 
that was tested for efficient recombination [Supplemental Figure 
1, A–E] was used in all experiments that used conditional alleles). 
Pten is a phosphatase that counteracts the action of growth factors 
such as insulin by decreasing intracellular levels of the second 
messenger phosphatidylinositol-trisphosphate (PIP3) (Figure 1). 
Therefore, activation of the pathway by loss of PTEN is not sensi-
tive to the negative-feedback loop of the insulin/mTOR pathway, 
as PIP3 levels remain high even after growth factor receptors are 
turned off by the feedback loop (28). As a consequence of sus-
tained pathway activity, we found that cone survival was signifi-
cantly improved in retinae of rd1 PtencKO mice up to 8 months of 
age when compared with cone survival in Cre– littermate control 
retinae (Figure 2, A and B, and Supplemental Figure 2A) or with 
that observed in retinae following insulin injections in our previ-
ous study (17). The data suggest that sustained cell-autonomous 
activation of the pathway in cones can serve as a long-term thera-
peutic strategy to prolong cone survival in RP.
Loss of Pten activates various downstream signaling path-
ways and kinases. Two key kinases downstream of PTEN that 
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mTORC1 in rd1 Tsc1cKO retinae (Figure 4D). Loss of the protec-
tive effect by simultaneous ablation of TSC1 and RAPTOR, 
but not TSC1 and RICTOR, confirmed that mTORC1 activ-
ity was both required and sufficient to promote cone survival 
(Figure 5, A–C). Importantly, while mutations in TSC cause 
benign tumors in tissues such as the kidney and brain (37), 
loss of TSC1 in cones did not induce cone proliferation as 
assessed by the proliferation marker Ki67, indicating that the 
protection was due to improved cone survival and not cone 
numbers (Figure 5, D and E).
mTORC1 prolongs cone survival by improving cell metab-
olism. Photoreceptors are among the  most metabolically 
active cells in the human body (41), since they need to 
replenish membranes and proteins lost due to the daily shed-
ding of their OSs (42). Consequently, photoreceptors require 
large quantities of glucose to synthesize sufficient amounts of 
NADPH to keep up with daily membrane synthesis. mTORC1 is 
at the center of cell growth and proliferation, regulating genes 
involved in glycolysis, the pentose phosphate pathway (PPP), 
and de novo lipid synthesis (43). We therefore investigated 
whether sustained mTORC1 activity increases the expression 
of key metabolic target genes that increase NADPH produc-
tion in cones, thereby improving survival and function. As such, 
we analyzed the expression of glucose transporter 1 (GLUT1), 
which increases glucose uptake, hexokinase 2 (HK2), which 
phosphorylates glucose more effectively, and glucose-6-phos-
phate dehydrogenase (G6PD), which shunts glucose into the 
PPP for NADPH synthesis (44). Immunofluorescence analysis 
revealed an increase in the expression of all 3 aforementioned 
genes in cones of 2-month-old rd1 Tsc1cKO mice (Figure 6A and 
Supplemental Figure 3A). We did not observe this increase in 
immunofluorescence upon the concurrent loss of TSC1 and 
RAPTOR (Figure 6A), indicating that the increase was mTORC1 
dependent. Other glycolytic genes that contribute to an increase 
in NADPH production (45), such as pyruvate kinase muscle iso-
form 2 (PKM2) and malic enzyme 1 (ME1), were also revealed 
by immunofluorescence to be upregulated in cones of rd1 Tsc1cKO 
mice at 2 months of age, as was an increase in the transcription 
factor hypoxia-inducible factor 1 α (HIF-1α), which regulates 
known mTORC2- and AKT-mediated prosurvival mechanisms do 
not contribute to cone survival upon loss of PTEN (21, 28, 30).
To corroborate whether increasing mTORC1 activity alone is 
sufficient to prolong cone survival, we disrupted the tuberous scle-
rosis complex (TSC) (37), which is composed of the proteins TSC1 
and TSC2 and is a negative regulator of mTORC1 activity (ref. 21 
and Figure 1). Normally, the inhibitory effect of the complex on 
mTORC1 is released upon phosphorylation of TSC2 by activated 
AKT (21). However, removal of either TSC1 or TSC2 alone results 
in a more robust and constitutive activation of mTORC1. Thus, 
we used mice with a conditional allele for Tsc1 to disrupt the TSC 
in cones of rd1-mutant mice (rd1 M-opsin-Cre Tsc1fl/fl mice, herein 
referred to as rd1 Tsc1cKO) (38). At 2 months of age, loss of TSC1 in 
these mice resulted in a more pronounced rescue of cones when 
compared with loss of PTEN (Figure 4, A and B). Many of the reti-
nae displayed an almost WT distribution of cones in central areas. 
The protective effect was significant up to 8 months of age (Figure 
4B). Cone function in these mice at 2 months of age, as evaluated 
by full-field electroretinography (ERG), was maintained at the 
levels recorded at the onset of cone death (P21), while it declined 
in Cre– animals (Figure 4C). ERG recordings were low in the rd1 
mutant at the onset of cone death when compared with those in 
WT mice (~20% of WT), because rod degeneration starts before 
eye opening and before outer segments (OSs) have fully matured 
(13, 39, 40). When compared with loss of PTEN, S6 was uniformly 
phosphorylated in cones, demonstrating a robust activation of 
Figure 1. Schematic representation of the insulin/mTOR pathway. 
Upon insulin or growth factor binding, phosphosinositide 3-kinase 
(PI3K) increases the concentration of the second messenger PIP3, 
a reaction that is reversed by PTEN. Increased PIP3 levels promote 
mTORC2 and PDK1 activity. Both mTORC2 and PDK1 phosphorylate 
AKT on Ser473 and Thr308, respectively. While phosphorylation 
on both sites increases AKT activity, phosphorylation on Thr308 
is sufficient to promote AKT activity toward TSC. Activated AKT 
phosphorylates the TSC protein tuberin (TSC2), which releases the 
inhibitory function of the TSC1/TSC2 complex on mTORC1, resulting 
in increased mTORC1 activity. Activated mTORC1 phosphorylates and 
thereby activates its target ribosomal protein S6 kinase (S6K). S6K 
negatively feeds back to growth factor receptors by phosphorylation 
of the insulin receptor substrate (IRS), which prevents overactiva-
tion of the pathway. Activated S6K can also phosphorylate RICTOR, 
which is part of the mTORC2 complex. Phosphorylation of RICTOR by 
S6K reduces mTORC2-mediated activation of AKT. mTORC1 controls 
mainly progrowth processes, while mTORC2 and AKT regulate many 
prosurvival and apoptotic processes.
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NADPH in retinal extracts from WT mice in which TSC1 was 
ablated in cones by using the same Cre driver line (Figure 6B). 
Consistent with this, loss of TSC1 did not cause an increase in 
the expression of any of these genes in the cones of WT mice by 
2 months of age (Supplemental Figure 3B). However, phosphory-
lated S6 (p-S6) was readily detectable in the cones of WT mice 
lacking TSC1 (data not shown), confirming that mTORC1 activ-
ity was increased. In summary, sustained activation of mTORC1 
in cones improves cone survival and function under disease con-
ditions by gradually increasing the expression of genes involved 
in glucose uptake, retention, and utilization.
To further test whether NADPH levels are crucial for cone 
survival during disease, we examined the role of the initiator 
caspase, CASP2, a protease that initiates apoptotic cell death and 
has been shown to be activated under low intracellular NADPH 
levels but not low ATP levels (24, 25). Caspases are commonly 
activated by cleavage, thus the identification of a cleavage prod-
uct is generally used to assess caspase activity (49). Western blot 
analysis using retinal extracts from rd1 mice revealed no cleaved 
CASP2 products, while cleaved CASP2 was readily detectable 
after transfection of HEK239 cells with full-length Casp2 (Figure 
7A), suggesting that CASP2 is not cleaved during cone degen-
eration. However, because dimerization of initiator caspases is 
sufficient to activate the protease, albeit to a lesser extent, the 
absence of a cleavage product does not necessarily mean that 
a caspase is not active (49). To further test whether CASP2 was 
activated in cones, we performed immunofluorescence analy-
ses using 6 different CASP2 antibodies, none of which revealed 
any specific pattern of loss of CASP2 expression in the reti-
nae of Casp2–/– mice, making it difficult to determine whether 
CASP2 was actually expressed and activated in cones (data not 
the transcription of many glycolytic genes (ref. 46, Supplemen-
tal Figure 3A, and Supplemental Figure 4). The data suggest 
that glucose uptake, retention, and divergence into the PPP are 
improved. In agreement with these findings, we detected signifi-
cantly higher levels of NADPH in whole retinal extracts from rd1 
Tsc1cKO mice at P21 (Figure 6B), a time point at which cone death 
initiates but at which cone distribution was still similar between 
Cre– and Cre+ littermate controls (Supplemental Figure 5). Inter-
estingly, among the aforementioned metabolic genes, immun-
ofluorescence showed that only ME1 expression was increased 
at P21 (Supplemental Figure 6A). This suggests that while 
mTORC1 signaling is active at P21 (Figure 4D), the expression 
of these metabolic genes increases gradually over time.
To further test this finding, we performed quantitative 
RT-PCR (qRT-PCR) analysis at P21 and P24 and found that most 
metabolic genes started to display a modest but statistically sig-
nificant difference between Cre– and Cre+ retinae by P24 (Supple-
mental Figure 6, B and C). Performing the qRT-PCR or NADPH 
assay at a later time point would have complicated the interpre-
tation of the data, as the differences in cone density between Cre– 
and Cre+ retinae became statistically significant after P24 (Sup-
plemental Figure 5), and thus any difference could be attributed 
to the greater number of cones. In agreement with an improve-
ment in NADPH synthesis as well as a progressive increase in 
metabolic gene expression, we found that OS length was main-
tained in Cre+ mouse retinae between P21 and 2 months of age 
(Figure 6, C and D). Since NADPH is also essential for chromo-
phore recycling (47, 48), its increase, in conjunction with main-
tained OS length and a higher number of cones, may account 
for the higher ERG recordings in Cre+ animals at 2 months of 
age. Interestingly, we did not detect any significant increase in 
Figure 2. Loss of Pten promotes cone 
survival in rd1 mice. (A–C) rd1-mutant mice 
harboring the Ptenfl/fl allele. (A) Represen-
tative retinal flat mounts of rd1-mutant 
mice at 2 months of age showing more 
central cones in Cre+ animals (red signal 
indicates cone arrestin). Scale bar: 1 mm 
(left); 200 mm (right). (B) Quantification  
of cone survival at the indicated time 
points. Numbers in bars represent the 
number of retinae analyzed. **P < 0.01 and 
***P < 0.005 by Student’s t test. (C) Immu-
nofluorescence analyses at P21 of retinal 
flat mounts to detect phosphorylation of 
sites on the indicated proteins (red signal). 
Upper right of each panel shows magnifica-
tion of the area indicated by an arrow. Cone 
layer is identified by PNA staining (green 
signal indicates PNA; blue signal indicates 
nuclear DAPI). Scale bars: 20 mm (original 
magnification for insets, ×2.5).
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mice did not affect photoreceptor survival (Figure 7E). In sum-
mary, the data suggest that removal of an NADPH-sensitive cell 
death mechanism can delay cone death in RP, further supporting 
the notion that cone death in RP is intimately linked to glucose 
and NADPH levels and indicating that this cone death is likely a 
result of nutrient deprivation.
Constitutively activated mTORC1 delays cone death in 
rhodopsin-KO mice. To test whether improved cone survival medi-
ated by increased mTORC1 activity is applicable to other models 
of RP, we used the rhodopsin-KO (Rho–/–) (23) mouse, which dis-
plays slower degeneration kinetics. Cone death initiates at around 
17 weeks of age, and by 30 weeks of age, Rho–/– retinae show a 
degree of cone degeneration equivalent to that of 2-month-old 
rd1 mouse retinae (17). Similar to the observations made in the rd1 
mouse model, loss of TSC1 in the cones of Rho–/– mice was able to 
significantly prolong cone survival at 30 weeks of age (Figure 8, A 
and B). Moreover, increased immunoreactivity against metabolic 
genes such as HK2 and PKM2 in cones, as well as an increase in 
the number of cones positive for p-S6 (Figure 8C), indicates that 
the mechanism of protection is similar to that observed in rd1 
cones. These findings suggest that this approach is independent 
of the mutation in a rod-specific gene, allowing for therapeutic 
intervention at the mTORC1 level to prolong vision in RP.
shown). However, Western blot analyses using extracts of the 
photoreceptor-enriched retinoblastoma cell line Y79 revealed an 
immunoreactive band (Figure 7A), suggesting that CASP2 may 
be present in photoreceptors. To determine whether CASP2 was 
activated in cones without cleavage, we used a peptide bearing 
the CASP2 target sequence (VDVAD) conjugated with the flu-
orophore FITC. The peptide becomes covalently linked once 
bound to the active site of the protease, facilitating the clear-
ance of unbound excess peptide. Using this assay, we found that 
CASP2 activity occurred mainly in cones that lacked red-green 
opsin expression and displayed pyknotic nuclei, a key charac-
teristic of apoptotic cells (Figure 7B). Moreover, the pattern of 
cells positive for CASP2 activity reflected the central-to-periph-
eral progression of cone death, suggesting that we were indeed 
capturing dying cones across the retina. However, because the 
sequence of caspase-binding peptides is rather short, false-pos-
itives can occur. To test for specificity of the activity assay and 
to determine whether Casp2 plays a role in vivo during cone 
degeneration, we crossed the Casp2–/– allele onto an rd1-mutant 
background (Casp2–/– rd1). Loss of CASP2 not only abolished any 
CASP2 activity seen in rd1 retinae (Figure 7B), but also signifi-
cantly improved cone survival in the retinae of these mice at 
20 weeks of age (Figure 7, C and D), while loss of CASP2 in WT 
Figure 3. Raptor but not Rictor is required for loss of Pten-mediated survival. Data shown are from rd1-mutant mice harboring the indicated conditional 
alleles. (A and B) Representative retinal flat mounts (A) and quantification of cone survival (B) at 2 months of age (red signal indicates cone arrestin). 
Numbers in bars represent the number of retinae analyzed. ***P < 0.005 by Student’s t test. (C) Immunofluorescence analyses (red signal) of retinal flat 
mounts at P21 to detect phospho-specific sites on the indicated proteins(green signal indicates PNA; blue signal indicates nuclear DAPI).
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Discussion
In this study, we show that cell-autonomous activation of met-
abolic genes downstream of mTORC1 is sufficient to prolong 
cone survival in RP, suggesting that improving nutrient uptake, 
retention, and utilization in cones delays cone death during 
disease. Our data showing an almost WT distribution of cones 
upon loss of TSC1 in mice at 2 months of age hold great promise, 
as the rd1 mouse model is one of the fastest-progressing mod-
els of RP. Because cone death is also significantly delayed in the 
slow-progressing Rho–/– model of RP, the approach is predicted 
to be mutation independent and thus to improve cone survival 
across a wide spectrum of RP diseases in which the primary 
mutation is in a rod-specific gene.
Loss of the TSC has been shown in cell culture systems to ren-
der cells sensitive to complete glucose withdrawal, since mTORC1 
fails to balance demand with supply (50). However, low nutrient 
conditions such as reduced glucose levels confer a survival advan-
tage to cells that lose the TSC (51). This is because sustained 
mTORC1 activity under nutrient-restrictive conditions maintains 
protein synthesis and therefore allows for increased expression of 
transporters and other metabolic genes that help counterbalance 
the nutrient shortage. Similar to the findings in cell culture, loss of 
TSC in mouse cones confers a survival advantage during disease 
and increases the expression of transporters and metabolic genes. 
Therefore, increased mTORC1 activity helps starving cones to 
balance nutrient demand with supply. Consistent with this idea, 
loss of mTORC1 activity accelerates cone death in RP as cones fail 
to adapt to the nutrient shortage, while its activity is not required 
to keep cones alive in WT mice up to 2 months of age, since cones 
in these mice do not experience a nutrient shortage. Thus, the 
basal expression of many of these metabolic genes does not seem 
be to regulated by mTORC1 in cones, since its loss does not affect 
cones of WT mice up to 2 months of age. Our data suggest that 
the induction of mTORC1 target genes upon loss of TSC1 func-
tions as an adaptive response in cones to counter nutrient stress. 
This idea is further supported by the finding that the expression of 
these metabolic genes increases gradually from P21 onward and 
is seen only in rd1 and not WT retinae upon loss of TSC1. While 
this may appear at odds with in vitro data, in which loss of the TSC 
automatically increases the expression of mTORC1 targets (43), it 
is important to note that our experiments were carried out in vivo 
in postmitotic neurons within the context of a tissue. Thus cell 
Figure 4. Activation of mTORC1 promotes cone survival and maintains cone function in rd1-mutant mice. (A–D) rd1-mutant mice harboring the 
Tsc1fl/fl allele. (A) Representative retinal flat mounts from rd1-mutant mice at 2 months of age showing a higher concentration of central cones in Cre+ 
animals (red signal indicates cone arrestin). Scale bars: 1 mm (left); 200 mm (right). (B) Quantification of cone survival at the indicated time points. 
Numbers in the bars represent the number of retinae analyzed. *P < 0.05 and ***P < 0.005 by Student’s t test. (C) Evaluation of cone function by 
photopic ERG recordings in mice at P21 and 2 months of age showing b-wave amplitude, the average response time of the b-wave peak, and represen-
tative recordings in animals at 2 months of age (left to right). The same ERG protocol was used for WT and rd1 animals. Numbers in the bars represent 
the number of animals analyzed. ***P < 0.005 by Student’s t test. (D) Immunofluorescence analyses to detect p-S6 on 2 different mTORC1-dependent 
sites (red signal) at P21 (green indicates PNA; blue indicates nuclear DAPI). Scale bar: 20 mm (original magnification for insets, ×2.5).
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type–specific differences may account for this discrepancy. Sim-
ilarly, loss of PTEN, which generally increases the activity of both 
mTOR complexes and AKT (21), results in decreased mTORC2 
activity and decreased p-AKT (Ser473) in cones.
Cellular redox potential is tightly linked to nutrient availabil-
ity. For example, NADPH is used to reduce oxidized glutathione, 
which serves to scavenge many free radicals. Increased NADPH 
levels upon loss of TSC1 likely contribute to cone survival through 
2 different mechanisms. First, because NADPH is required for 
lipid and thus OS synthesis, increased levels can help prevent the 
OS shedding rates exceed the synthesis rate, thereby maintaining 
OS length, which can improve photoreceptor function. Photore-
ceptor function is also directly linked to NADPH, since NADPH 
is required to recycle the visual chromophore (47, 48). An overall 
healthier and better-functioning photoreceptor is likely to survive 
longer. Second, because oxidative stress is known to occur during 
the periods of cone degeneration, increased NADPH levels can 
directly reduce oxidative stress by increasing glutathione avail-
ability (52). Therefore, starvation of cones in RP is consistent with 
a model of increased oxidative stress as a contributing 
factor to cone death (52). However, oxidative stress 
itself is unlikely to be the sole cause for cone death in 
RP, since antioxidant treatments have had limited suc-
cess in prolonging cone survival (13–16).
An understanding of the cell death mechanisms 
for cone death in RP remains largely elusive. Iden-
tifying a cell death mechanism may shed light on 
the overall cause of cell death, as some mechanisms 
require specific stress conditions or triggers. In this 
regard, the identification of Casp2 as the first apoptotic 
mechanism for cone death in RP further corroborates 
the notion that low NADPH levels are a contributing 
factor to cone death and supports the overall idea 
of a nutrient shortage in cones. However, a delay in 
cone death is only seen at later stages. This could be 
due in part to the involvement of necrosis during the 
initial phase of cone death. A recent report showed 
that early cone death in the rd10 mouse model of RP 
includes necrotic cell death (53). The rd10 model har-
bors a different mutation in the same gene as that in 
the rd1 model; however, rod death progresses slightly slower than 
in the rd1 model, yet is still faster than in the Rho–/– model. The 
electron microscopic analyses performed in that study revealed 
several cone nuclei with necrotic features at early stages of cone 
death. Additionally, the study showed that inhibition of necro-
sis reduces the number of necrotic nuclei and delays early cone 
death. Nonetheless, a greater number of cone nuclei showed 
signs of apoptotic cell death, even at early stages. Early necrotic 
cone death could be due to the rapidly occurring structural insult 
on the retina because of the rather rapid loss of rods. Once the 
necrotic phase ceases, the remaining cones may die by apop-
totic mechanisms, including the activation of CASP2 induced by 
low NADPH levels. Early necrosis could explain why cone death 
progresses rapidly within the first days (P21–P28; Supplemental 
Figure 5), before activation of mTORC1 turns on the metabolic 
transcriptional network that delays cone death upon loss of TSC1. 
In combination with early necrosis, there are likely additional, as 
yet unidentified cell death mechanisms that contribute to cone 
death. These could explain why loss of CASP2 does not result in a 
Figure 5. mTORC1 is sufficient to prolong cone survival 
in RP. (A–C) Data shown are from mice on an rd1-mutant 
background harboring the indicated conditional alleles. (A) 
Representative retinal flat mounts from mice at 2 months of 
age (red signal indicates cone arrestin). Scale bar: 1 mm. (B) 
Quantification of cone survival in mice at 2 months of age. 
Numbers in the bars represent number of retinae analyzed. 
*P < 0.05 and ***P < 0.005 by Student’s t test. (C) Immun-
ofluorescence analyses of retinal flat mounts to detect p-S6 
at P21. p-S6 was absent from the cone layer (green signal 
indicates PNA) upon loss of TSC1 and RAPTOR, while the 
number of cones positive for p-S6 increased upon loss of TSC1 
and RICTOR (blue signal indicates nuclear DAPI). Scale bar: 
20 mm. (D and E) Ki67 staining (red signal) in retinae of rd1 
Tsc1cKO mice at 2 months of age (D) and WT mice at P0 (E), 
when cell division is ongoing (green signal indicates PNA; blue 
signal indicates nuclear DAPI). Higher magnification (×30) is 
shown on the right side of each panel. Scale bar: 20 mm.
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targets in cones may provide a feasible approach for future treat-
ments in humans. This approach rests on the identification of the 
correct combination of target genes required to prolong cone sur-
vival. Alternatively, drugs that increase mTORC1 activity could be 
delivered to the retina through slow-releasing eye implants.
It is of interest to note that the most common form of photore-
ceptor degeneration and thus the major cause for blindness in the 
industrialized world, age-related macular degeneration (AMD), 
may result in photoreceptor death due to the same proposed 
mechanism by which cones die in RP. In AMD, RPE cell function 
and health are affected, as the accumulation of drusen between 
the RPE and choriocapillary impinges on nutrient transfer from 
the bloodstream to RPE cells (54). Because RPE cells are the main 
source of nutrients for photoreceptors, a reduction in nutrient 
availability to RPE cells inevitably affects photoreceptors, too. 
Thus AMD and RP, although having different etiologies, may both 
result in blindness caused by starving cones. Therefore, improv-
ing photoreceptor metabolism by increasing mTORC1 activity 
may be applicable not only to RP, but also holds great promise 
for treating the most common form of retinal degeneration in the 
industrialized world.
Methods
Animals. Mice were maintained on a 12-hour light/12-hour dark cycle 
with unrestricted access to food and water. Lighting conditions were 
more profound effect. One would expect these mechanisms to be 
linked either directly or indirectly to low intracellular energy lev-
els, as improving cell metabolism through activation of mTORC1 
effectively delays cone death. For example, reduced NADPH lev-
els could induce cell death through oxidative stress before CASP2 
is activated. Thus, removal of one of the cell death mechanisms 
such as loss of CASP2, or treatments with antioxidants, is not 
sufficient to achieve the same effect that is seen with treating the 
overarching problem of starvation through loss of TSC1.
In summary, activation of the metabolic gene regulatory net-
work downstream of mTORC1 significantly improved cone sur-
vival in a cell-autonomous manner, suggesting that the overall 
cause of cone death was nutrient shortage, in particular, a glu-
cose shortage. Cone cell death itself is likely executed by a mul-
titude of mechanisms, since in addition to the nutrient shortage, 
cones experience a variety of insults such as increased oxidative 
stress that occur at the same time due to the massive loss of rods. 
The insult causing the largest stress in any given cone may then 
determine the cell death mechanism used. This may explain why 
individual approaches have only limited success in delaying cone 
death in RP. Although our findings may not be directly translatable, 
since cell type–specific loss of the tumor-suppressor genes Pten or 
Tsc1 is not advisable in humans, they may redirect efforts aimed 
at developing therapies for patients suffering from RP. For exam-
ple, adeno-associated virus–mediated gene transfer of mTORC1 
Figure 6. mTORC1 activation improves glucose metabolism in cones. (A) Immunofluorescence analyses to detect the indicated proteins (red signal) on 
retinal flat mounts from 2-month-old rd1 mice harboring the indicated conditional alleles. Concurrent loss of TSC1 and RAPTOR abolished the increase 
in immunoreactivity seen upon loss of TSC1 alone (green signal indicates PNA; blue signal indicates nuclear DAPI). Scale bar: 20 mm. (B) NADPH mea-
surements on whole retinal extracts at P21 from Tsc1fl/fl mice on WT and rd1-mutant backgrounds (ng/re, nanogram per retina). Error bars represent SD. 
*P < 0.05 by Student’s t est. Data are representative of 3 biological replicas, with 3 retinae per replica. (C) Representative images of OSs from WT (top 
panel) and rd1 Tsc1fl/fl mice (middle and bottom panels) at 2 months of age. (D) Quantification of OS length and width at the indicated time points.  
Error bars represent SD. ***P < 0.005 by Student’s t test. Data represent 40 measurements performed on 2 animals.
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the Cre+ and Cre– littermates that were used for analyses. Because 
various strains were interbred, strain background differences may 
account for the slight variations in cone survival in Cre– animals at 
2 months of age. Nonetheless, our data clearly show that mTORC1 
was required for cone survival during disease, since loss of RAPTOR 
always accelerated cone death, while increasing mTORC1 activity 
consistently improved cone survival. Because loss of Casp2 did not 
allow us to compare Cre– and Cre+ littermates, we generated a con-
genic rd1 Casp2–/– line to study the effect of loss of CASP2 on cone 
survival. The Casp2–/– allele was on a C57BL/6J background and was 
crossed with rd1 C57BL/6J mice that were generated by backcrossing 
the Pde6brd1/rd1 allele of the FVB strain with C57BL/6J mice for 10 gen-
erations. rd1 C57BL/6J mice were then compared with rd1 Casp2–/– 
C57BL/6J mice to quantify cone survival.
ERG. ERG was performed using the Espion E3 console in conjunc-
tion with the ColorDome (Diagnosys LLC). Mice were anesthetized 
kept constant in all cages, with illumination ranging between 10 and 
15 lux. The Pde6brd1/rd1 (rd1), Casp2–/–, C57BL/6J, Ptenfl/fl, Tsc1fl/fl, and 
Ai9 Cre reporter mice were purchased from The Jackson Laboratory 
(20, 26, 27, 38, 55). The M-opsin-Cre (cone-specific Cre line using 
the human medium wavelength promoter), Raptorfl/fl, Rictorfl/fl, and 
Rho–/– mice have been described previously by Yun Z. Le, Michael 
N. Hall, Markus A. Rüegg, and Janis Lem, respectively (22, 23, 35). 
Genotyping was performed as described in the original publications. 
None of the mice used for analysis were on an albino background, 
and all mice were genotyped for absence of the rd8 mutation (56). To 
dissect the role of the insulin/mTOR pathway in cone survival, the 
conditional allele was first crossed with the cone-specific Cre-driver 
line and then with the rd1 line to generate Cre– and Cre+ rd1–condi-
tional allele (cKO) lines. In some cases, double-conditional alleles 
were also generated. The Cre+ and Cre– lines were crossed with each 
other (e.g., rd1 Ptenfl/fl rd1 Ptenfl/fl M-opsin-Cre+/–  Ptenfl/fl) to generate 
Figure 7. Loss of Casp2 slows cone death. (A) Western blot analyses of full-length and cleaved CASP2 in retinal extracts from the indicated genotypes 
(left blot) and in cell culture extracts (right blot) from HEK293 cells, HEK293 cells transfected with full-length Casp2, and in extracts from the photore-
ceptor-enriched retinoblastoma cell line Y79. (B) Immunofluorescence to detect active CASP2 (green signal indicates FITC-labeled CASP2 activity peptide) 
and red-green opsin (red signal) in retinae of 2-month-old animals. Top row, left to right: Retinal flat mount showing the CASP2-active zone (between 
the dotted lines) of cell death progressing toward the periphery. Middle panel: No CASP2 activity was detected in the absence of Casp2. Right panel: 
Higher magnification of central-to-peripheral death wave is demarked by the dotted line. To the left of the line, little CASP2 activity was seen, and many 
cells still expressed red-green opsin (red signal), while to the right of the line, there were few red-green opsin–positive cells and many cells positive for 
activated CASP2. Bottom panels: higher magnification showing that cells with more CASP2 activity (arrowheads) had pyknotic nuclei and less red-green 
opsin immunoreactivity as opposed to cells with more red-green opsin immunoreactivity (arrows; blue signal indicates nuclear DAPI). (C) Representative 
retinal flat mounts from mice of the indicated genotypes at 10 and 20 weeks of age. (D) Quantification of cone survival in rd1 and Casp2–/– rd1 mice at the 
indicated time points. Numbers in the bars represent the number of retinae analyzed. *P < 0.05 by Student’s t test. (E) Immunofluorescence analyses to 
detect cone arrestin (red signal) and PNA (green signal; blue signal indicates nuclear DAPI) in retinal cryosections from 20-week-old WT and Casp2–/– mice.
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lectin (PNA) (1:500; catalog FL-1071; 
Vector Laboratories). All secondary 
antibodies (donkey) were purchased 
from Jackson ImmunoResearch and 
were purified F(ab)2 fragments that 
displayed minimal cross-reactivity 
with other species.
Quantification of cone survival. The 
Ai9 Cre-reporter line was used to validate uniform expression of Cre 
recombinase across the retina (Supplemental Figure 1, A–E, and ref. 
55). Quantification of cone survival by colocalization was performed 
using a method similar to one described previously (17). In brief, the 
percentage of surviving cones is based on a calculation of the percent-
age of the retinal surface area that is covered by cones. To determine 
the area that was covered by cones, we used the staining detected by 
the cone arrestin antibody (Supplemental Figure 1, F and G: red sig-
nal) as a proxy for surviving cones. To determine the retinal surface 
area, retinae were stained with PNA-coupled FITC (Supplemental 
Figure 1, F and G: green signal in the first and last columns and gray 
scale signal in the third column) at a dilution that was 3 times higher 
than that used for all other staining procedures, with the goal to only 
elicit sufficient background fluorescence to highlight the entire reti-
nal surface area rather than detect cone OSs. The ratio of red to green 
pixels, which was calculated using CoLocalizer Pro software (CoLo-
calization Research Software) (58) with its integrated background 
correction, thus directly representing the percentage of the retinal 
surface area that was covered by the cone arrestin antibody staining. 
Before calculating the percentage of colocalization of red and green, 
the upper and lower thresholds of each signal were adjusted, such that 
only cones were visible in the red signal (Supplemental Figure 1, H and 
I), and the entire retina was visible in the green signal. To calibrate 
the percentage of colocalization of red and green signals on an rd1- 
mutant background to the actual percentage of surviving cones, we 
performed a real cone count rather than determining the percentage 
of cone arrestin staining that covered the retina in WT mice. The rea-
son for this is that during degeneration, cone arrestin was also found 
in the cell body, resulting in a different pattern of expression; thus, the 
percentage of colocalization was different when compared with that 
in retinae of WT mice (Supplemental Figure 1, J and K). A cone count 
was performed across 3 WT retinae and across 3 rd1 Tsc1cKO retinae at 
P21 (Supplemental Figure 1, L–N). The mutant strain and time point 
were chosen at P21, since at this point, cone death had just started, 
by an i.p. injection of a ketamine-xylazine (100 mg/kg and 10 mg/kg, 
respectively) mixture. One drop  each of phenylephrine (2.5%) and 
tropicamide (1%) was applied for pupil dilation 10 minutes before to 
recording. Animals were kept on a warming plate during the entire 
ERG procedure to maintain body temperature at 37°C. Photopic ERGs 
were recorded after light adaptation with a background illumination 
of 34 cd/m2 (white 6500 K, produced by a Ganzfeld stimulator) for 
8 minutes. Flashes were presented at 1-minute intervals with a pulse 
length of 4 ms, and each recording consisted of a single flash of 
35 cd × s/m2. Six to nine trials were averaged for single-flash responses.
Histological methods. Antibody stainings on retinal cryosections 
and retinal flat mounts were performed as described previously (17, 
57). CASP2 activity on retinal whole mounts was detected using the 
Green FLICA Caspase 2 Activity Kit (catalog 918; ImmunoChem-
istry Technologies) according to the manufacturer’s instructions. 
Briefly, retinae were incubated in DMEM media with the detection 
reagent at 37°C for 30 minutes, followed by 2 washes of 5 minutes 
each in apoptosis wash buffer. Retinae were then fixed and processed 
for antibody staining as described (17, 57). Antibody stainings were 
performed in TBS buffer for phospho-specific antibodies and in PBS 
buffer for all other antibodies. The following primary antibodies and 
concentrations were used: rabbit α–p-AKT (Thr308) (1:1,000; cata-
log 2965); rabbit α–p-AKT (Ser473) (1:1,000; catalog 4060); rabbit 
α–p-S6 (Ser240) (1:300; catalog 5364); rabbit α–p-S6 (Ser235/236) 
(1:300; catalog 4856); rabbit α-PKM2 (1:300; catalog 4053); rabbit 
α-HK2 (1:300; catalog 2867) (all from Cell Signaling Technology); 
rabbit α–p-SGK (Ser422) (1:300; catalog ab55281); rabbit α-G6PD 
(1:300; catalog ab993); rabbit α-ME1 (1:300; catalog ab97445); 
rabbit α-Ki67 (1:300; catalog ab15580) (all from Abcam); rabbit 
α–HIF-1α (1:300; catalog ab1536; R&D Systems); rabbit α-GLUT1 
(1:30; catalog GT11-A; Alpha Diagnostics); mouse α-Cre (1:500; cat-
alog MMS-106P; Covance); rabbit α–cone arrestin (1:300; catalog 
AB15282; EMD Millipore); rabbit α–red-green opsin (1:300; catalog 
AB5405; EMD Millipore); and fluorescein-labeled peanut agglutinin 
Figure 8. Cone protection mediated by 
loss of TSC1 is conserved in RP. Data 
shown are from Rho–/– mice harboring 
the Tsc1fl/fl allele. (A) Representative 
retinal flat mounts from mice at 30 
weeks of age (red signal indicates cone 
arrestin). Scale bar: 1 mm. (B) Quanti-
fication of cone survival in mice at 30 
weeks of age. Numbers in the bars rep-
resent the number of retinae analyzed. 
***P < 0.005 by Student’s t test. (C) 
Immunofluorescence analyses to detect 
the indicated proteins (red signal) on 
retinal flat mounts (green signal indi-
cates PNA; blue signal indicates nuclear 
DAPI). Scale bar: 20 mm. 
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tions were performed either in TBS buffer for phospho-specific anti-
bodies or in PBS buffer for all other antibodies. The following primary 
antibodies were used: rabbit α–p-AKT(308) (1:1,000; catalog 2965); 
rabbit α–p-AKT(473) (1:1,000; catalog 4060); mouse α-AKT (1:1,000; 
catalog 2967); rabbit α–p-S6 (1:1,000; catalog 5364); and rabbit α-S6 
(1:1,000; catalog 2217) (all from Cell Signaling Technology); mouse 
α-β–actin (1:2,000; catalog A5316; Sigma-Aldrich); mouse α-CRE 
(1:2,000; catalog 69050-3; Novagen); rabbit α-cone arrestin (1:1,000,; 
catalog AB15282; EMD Millipore); and rat α-CASP2 (1:1,000; catalog 
ALX-804-356; clone 11B4; Enzo Life Sciences).
qRT-PCR. RNA was isolated using TRIzol (Life Technologies) as 
described previously (17). Three biological samples of each genotype 
were analyzed, and each sample consisted of retinae from 2 different 
animals. cDNAs were generated using the Transcriptor First Strand 
cDNA Synthesis Kit (Roche Diagnostics), and SYBR green–based 
qRT-PCR (Kapa Biosystems) was performed using the Bio-Rad 
CFX96 Real-Time System. Samples were run in duplicate and nor-
malized to β-actin using the 2–ΔΔCt method. The primer sets used are 
provided in Supplemental Table 1.
NADPH measurement. NADPH was measured using the Fluoro 
NADP/NADPH kit from Cell Technology Inc. (NADPH100-2). The 
assay was performed in triplicate using 3 biological samples, with each 
biological sample consisting of 3 retinae. Retinae were dissected in 
DMEM media, rinsed with 1X PBS, and processed following the man-
ufacturer’s instructions. Retinae were sonicated after the addition of 
the lysis buffer to ensure efficient dissociation.
Cell culture. Casp2 was amplified by PCR (forward: 5′-ATGGC-
GGCGCCGAGCGGGAGGTCG-3′; reverse: 5′-TCACGTGGGTGGG-
TAGCCTGGG-3′) from a C57BL/6J retinal cDNA library that was gen-
erated as described previously (17). The PCR product (1359 bp) was 
subcloned into the pGEM-T easy vector (Promega) and sequence ver-
ified. The Casp2 cDNA was then cloned into an rAAV2 plasmid carry-
ing a CMV promoter and the SV40 polyadenylation site. HEK293 cells 
were transfected with PEI (23966; Polyscience Inc.) and maintained 
in regular DMEM media containing 10% FCS and a penicillin-strep-
tomycin mixture. The same media were used to maintain the Y79 cell 
line. Protein extractions were performed as described above.
Statistics. The Student’s t test was used for statistical analyses. 
P values of less than 0.05 were considered statistically significant. If not 
otherwise noted in the figure legend, all error bars represent the SEM.
Study approval. The IACUC of the University of Massachusetts 
Medical School approved the animal study. All procedures involv-
ing animals were performed in compliance with the Association for 
Research in Vision and Ophthalmology (ARVO) Statement for the Use 
of Animals in Ophthalmic and Vision Research. 
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and the percentage of colocalization of red and green signals was the 
highest upon loss of TSC1 (52.7%). The actual cone count in WT ret-
inae was in agreement with published data (59) and revealed that at 
P21, 95.2% of cones were still present in the rd1 Tsc1cKO retinae when 
compared with those in WT retinae, meaning that 52.7% of colocal-
ization (red to green signal) corresponds to 95.2% of cones. These 
numbers were used to calibrate all colocalization data representing 
cone survival. To validate the method, we counted cones in retinae of 
rd1 Tsc1cKO mice at 2 months of age (Supplemental Figure 1, L–N). This 
time point was chosen because upon loss of TSC1, cone survival at 2 
months of age is still quite homogenous, rather than demonstrating a 
patchy pattern of survival, thus making it more accurate to determine 
the number of cones across the entire retina by counting individual 
fields. The colocalization and actual cone count data for mice at 2 
months of age were in agreement, with no statistically significant dif-
ference between them (77.6% ± 3.9% vs. 75.8% ± 3.7%, respectively), 
indicating that the colocalization method can be used to determine 
the percentage of surviving cones. The method of quantifying cones 
by colocalization over the entire retinal surface, rather than counting 
the number of cones in a few individual fields, was chosen because 
cone degeneration is quite patchy, progressing from the center to the 
periphery. Therefore, counting a few individual fields, even if always 
done in the exact same location, is not likely to properly represent the 
number of surviving cones. Thus, this method is independent of the 
degeneration pattern and the orientation of the retina.
For quantification of cones by cone count, retinae were first 
divided into 5 different sectors with increasing radiuses of 500 mm 
per sector (Supplemental Figure 1L). Cones were then counted man-
ually in 4 squares per sector (20 squares/retina), each square measur-
ing 40,000 mm2, to determine the average cone density per sector 
(cones/mm2). The average cone density per sector was then multi-
plied with the sector surface area to obtain the number of cones per 
sector. The surface area of each sector was calculated as the sector 
surface area of a sphere. The total number of cones per retina was 
then obtained by adding the number of cones across the 5 sectors. 
The numbers shown represent an average of 3 retinae per genotype 
and age. Retinal flat-mount images for the colocalization analyses 
and cone count were acquired by tiling individual images taken at ×16 
magnification (Leica DM5500) over the entire retinal surface area 
with an automated scanning stage.
Western blot analysis. Retinae from 2 animals were pooled and 
homogenized by sonication in ristocetin-induced platelet aggregation 
(RIPA) buffer containing protease and phosphatase inhibitors (cOm-
plete Protease Inhibitor Cocktail and PhosSTOP Phosphatase Inhibi-
tor Cocktail; both from Roche Diagnostics). Protein concentration was 
assessed using a Protein Assay Kit (Bio-Rad), and 10 μg protein was 
loaded per lane. Proteins were separated on a 4%–20% Tris-Glycine 
gradient gel (Bio-Rad) at 170 V and transferred onto a nitrocellulose 
membrane for 2 hours at 4°C with a current of 150 mA. Membrane 
was blocked for 1 hour at room temperature in 5% fat-free dry milk 
powder, incubated with primary antibody overnight at 4°C, washed 
3 times for 20 minutes each wash at room temperature, incubated 
with an HRP-coupled secondary antibody (1:10,000; Santa Cruz Bio-
technology Inc.) for 2 hours, and washed 3 times for 20 minutes each 
wash at room temperature. Signal was detected with SuperSignal West 
Dura (Pierce Biotechnology). All incubations were performed in the 
presence of 0.1% Tween-20 and 5% fat-free dry milk powder. Incuba-
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